At its peak, Imcivree’s sales in hypothalamic obesity could reach over $2 billion worldwide, according to analysts at Stifel.

You may have missed it due to the firehose of international news over the last week. But in between the CIA director traveling to Venezuela to meet deposed dictator Nicolás Maduro’s replacement and ...

A Metropolitan Transportation Authority rendering shows a conceptual interior of a future Second Avenue Subway station in Harlem, illustrating platform circulation, train clearances and passenger flow ...

President Donald Trump’s administration formally launched the second phase of its plan to end the war between Israel and Hamas this week, shifting from a ceasefire framework toward a post-ceasefire ...

OASIS+ is a suite of six multiple-award, indefinite-delivery/indefinite-quantity contracts with a five-year base period and a five-year option term. The contract ...

Michael Block is a 14 time GLAM Award nominated writer, producer, and host of the podcast Block Talk. Throughout his time in the entertainment industry, he has worked on and off Broadway as a stage ...

Success rates in phase II and phase III clinical trials are recognized as two of the most powerful drivers of overall efficiency in drug development (Nat. Rev. Drug Discov. 23, 656–657; 2024). With ...

Kelluu produces hydrogen-powered airships, providing aerial sensing capability as a service. Above, testing during NATO ‘REPMUS 2025'. (NATO DIANA) NATO's Defence Innovation Accelerator for the North ...

On this date six years ago, the graffiti world and the entire Hip Hop community lost one of its most influential pioneers. Michael Lawrence Marrow, better known as True Mathematics Allah and globally ...

The General Services Administration has launched the second phase of the One Acquisition Solution for Integrated Services Plus, or OASIS+, contract program, adding five new service domains as part of ...

FOSTER CITY, Calif.--(BUSINESS WIRE)--Mirum Pharmaceuticals, Inc. (Nasdaq: MIRM), a leading rare disease company, today announced that the first participant has been enrolled in the BLOOM Phase 2 ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. A novel GLP-1 and amylin receptor agonist reduced HbA1c ...